MASSACHUSETTS GENERAL HOSPITAL
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma
- Conditions
- PDAC - Pancreatic Ductal Adenocarcinoma
- First Posted Date
- 2025-07-02
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT07047807
- Locations
- ๐บ๐ธ
Massachusetts General HospitaL, Boston, Massachusetts, United States
Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)
- First Posted Date
- 2025-07-02
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT07047209
- Locations
- ๐บ๐ธ
MGH, Boston, Massachusetts, United States
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
- Conditions
- PreeclampsiaGestational Hypertension
- Interventions
- Drug: Placebo tablet to match spironolactone
- First Posted Date
- 2025-06-27
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 204
- Registration Number
- NCT07041281
- Locations
- ๐บ๐ธ
Massachusetts General Hospital, Boston, Massachusetts, United States
๐บ๐ธBrigham and Women's Hospital, Boston, Massachusetts, United States
๐บ๐ธUniversity of Pittsburgh Magee-Womens Hospital, Pittsburgh, Pennsylvania, United States
Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
- Conditions
- Crohn DiseaseInflammatory Bowel DiseasesHealthy
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT07033208
- Locations
- ๐บ๐ธ
Massachusetts General Hospital, Boston, Massachusetts, United States
Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma
- Conditions
- Relapsed Refractory Multiple Myeloma (RRMM)
- Interventions
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 25
- Registration Number
- NCT07032714
- Locations
- ๐บ๐ธ
Massachusetts General Hospital, Boston, Massachusetts, United States
๐บ๐ธBeth Israel Deaconess Medical Center, Boston, Massachusetts, United States
๐บ๐ธDana-Farber Cancer Institute, Boston, Massachusetts, United States
Risk Informed Obesity Care Plan Pilot
- Conditions
- Childhood Obesity
- First Posted Date
- 2025-06-19
- Last Posted Date
- 2025-06-19
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 720
- Registration Number
- NCT07028814
- Locations
- ๐บ๐ธ
Massachusetts General Hospital, Boston, Massachusetts, United States
The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes
- Conditions
- AnesthesiaSedationSurgerySurgery ScheduledFasting Before OperationMonitored Anesthesia CareSurgery, DayProcedureAspiration; Gastric Contents, Anesthesia
- First Posted Date
- 2025-06-15
- Last Posted Date
- 2025-06-15
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 1200000
- Registration Number
- NCT07022951
- Locations
- ๐บ๐ธ
Mass General Brigham, Boston, Massachusetts, United States
Addressing Emotional Distress in Dyads of Persons With a Young Onset Dementia (YOD) and Their Care-partners
- Conditions
- Young Onset Dementia
- First Posted Date
- 2025-06-12
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 388
- Registration Number
- NCT07018726
- Locations
- ๐บ๐ธ
Massachusetts General Hospital (MGH), Boston, Massachusetts, United States
Pomalidomide for the Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia Longitudinal Assessment Study
- Conditions
- Hereditary Hemorrhagic Telangiectasia (HHT)
- First Posted Date
- 2025-06-12
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 62
- Registration Number
- NCT07018401
- Locations
- ๐บ๐ธ
University of California-San Diego, San Diego, California, United States
๐บ๐ธUniversity of California-San Francisco, San Francisco, California, United States
๐บ๐ธUniversity of Florida, Gainesville, Florida, United States
A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
- Conditions
- Lymphoma
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 254
- Registration Number
- NCT07013435
- Locations
- ๐บ๐ธ
Mass General Hospital, Boston, Massachusetts, United States